Exicure, Inc. (XCUR )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol XCUR
- Company Exicure, Inc.
- Price $11.19
- Changes Percentage 92.27
- Change 5.37
- Day Low $6.83
- Day High $14.8
- Year High $14.8
- Year Low $1.44
- Market Cap $24,308,294
- Price Avg 50 EMA (D) $2.81
- Price Avg 200 EMA (D) $2.55
- Exchange NASDAQ
- Volume 22,842,607
- Average Volume 1,110,291
- Open $6.84
- Previous Close $5.82
- EPS -2.02
- PE -5.54
- Earnings Announcement 2025-03-06 12:00:00
- Shares Outstanding $2,172,323
Company brief: EXICURE, INC. (XCUR )
- Healthcare
- Biotechnology
- Mr. Paul Kang
- https://www.exicuretx.com
- US
- N/A
- 05-22-2018
- US30205M2008
Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie Inc. to develop SNA-based treatments for hair loss disorders; and collaboration agreement with Ipsen S.A. to research, develop, and commercialize novel spherical nucleic acids for Huntington's disease and Angelman syndrome. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.